These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38042762)

  • 1. Prediction of macrotrabecular-massive hepatocellular carcinoma by using MR-based models and their prognostic implications.
    Chai F; Ma Y; Feng C; Jia X; Cui J; Cheng J; Hong N; Wang Y
    Abdom Radiol (NY); 2024 Feb; 49(2):447-457. PubMed ID: 38042762
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
    Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma.
    Zhu Y; Weng S; Li Y; Yan C; Ye R; Wen L; Zhou L; Gao L
    Abdom Radiol (NY); 2021 Jul; 46(7):3139-3148. PubMed ID: 33641018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
    Zhang Y; He D; Liu J; Wei YG; Shi LL
    World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysis.
    Kim TH; Woo S; Lee DH; Do RK; Chernyak V
    Eur Radiol; 2024 Oct; 34(10):6896-6907. PubMed ID: 38507054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multitask deep learning radiomics model for predicting the macrotrabecular-massive subtype and prognosis of hepatocellular carcinoma after hepatic arterial infusion chemotherapy.
    He X; Li K; Wei R; Zuo M; Yao W; Zheng Z; He X; Fu Y; Li C; An C; Liu W
    Radiol Med; 2023 Dec; 128(12):1508-1520. PubMed ID: 37801197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.
    Chen J; Xia C; Duan T; Cao L; Jiang H; Liu X; Zhang Z; Ye Z; Wu Z; Gao R; Shi Y; Song B
    Eur Radiol; 2021 Oct; 31(10):7696-7704. PubMed ID: 33856520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications.
    Rhee H; Cho ES; Nahm JH; Jang M; Chung YE; Baek SE; Lee S; Kim MJ; Park MS; Han DH; Choi JY; Park YN
    J Hepatol; 2021 Jan; 74(1):109-121. PubMed ID: 32818570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
    Mulé S; Galletto Pregliasco A; Tenenhaus A; Kharrat R; Amaddeo G; Baranes L; Laurent A; Regnault H; Sommacale D; Djabbari M; Pigneur F; Tacher V; Kobeiter H; Calderaro J; Luciani A
    Radiology; 2020 Jun; 295(3):562-571. PubMed ID: 32228294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
    Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
    Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of imaging findings of macrotrabecular-massive hepatocellular carcinoma using CT and gadoxetic acid-enhanced MRI.
    Cha H; Choi JY; Park YN; Han K; Jang M; Kim MJ; Park MS; Rhee H
    Eur Radiol; 2023 Feb; 33(2):1364-1377. PubMed ID: 35999373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-Energy CT Deep Learning Radiomics to Predict Macrotrabecular-Massive Hepatocellular Carcinoma.
    Li M; Fan Y; You H; Li C; Luo M; Zhou J; Li A; Zhang L; Yu X; Deng W; Zhou J; Zhang D; Zhang Z; Chen H; Xiao Y; Huang B; Wang J
    Radiology; 2023 Aug; 308(2):e230255. PubMed ID: 37606573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients.
    Zheng BH; Liu LZ; Zhang ZZ; Shi JY; Dong LQ; Tian LY; Ding ZB; Ji Y; Rao SX; Zhou J; Fan J; Wang XY; Gao Q
    BMC Cancer; 2018 Nov; 18(1):1148. PubMed ID: 30463529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
    Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
    Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
    Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
    Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma.
    Feng Z; Li H; Liu Q; Duan J; Zhou W; Yu X; Chen Q; Liu Z; Wang W; Rong P
    Radiology; 2023 Apr; 307(1):e221291. PubMed ID: 36511807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and Prognostic Ability of Contrast-Enhanced Unltrasound and Biomarkers in Hepatocellular Carcinoma Subtypes.
    Xu W; Huang B; Zhang R; Zhong X; Zhou W; Zhuang S; Xie X; Fang J; Xu M
    Ultrasound Med Biol; 2024 Apr; 50(4):617-626. PubMed ID: 38281888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma.
    Zhao YM; Xie SS; Wang J; Zhang YM; Li WC; Ye ZX; Shen W
    BMC Med Imaging; 2023 Sep; 23(1):138. PubMed ID: 37737166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
    Fan Y; Yu Y; Wang X; Hu M; Hu C
    BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.